objectivebecaus
decis
hospit
infant
bronchiol
often
support
subject
criteria
object
indic
bronchiol
sever
lack
test
hypothesi
lactat
dehydrogenas
ldh
releas
injur
cell
use
biochem
indic
bronchiol
sever
patient
methodsw
retrospect
analyz
studi
children
month
old
present
emerg
depart
bronchiol
demograph
clinic
inform
nasalwash
nw
serum
specimen
obtain
nw
sampl
analyz
respiratori
virus
caspas
activ
panel
cytokin
chemokin
total
ldh
activ
test
nw
sampl
sera
resultsof
enrol
children
median
age
month
nw
specimen
avail
viral
etiolog
found
patient
respiratori
syncyti
viru
rsv
rhinoviru
common
virus
detect
concentr
ldh
nw
specimen
independ
sera
higher
children
rsv
infect
dual
infect
signific
correl
found
nw
ldh
nw
cytokin
chemokin
similarli
nw
ldh
correl
nwcaspas
activ
p
multivari
analysi
nw
ldh
concentr
upper
quartil
significantli
associ
reduc
risk
hospit
odd
ratio
confid
interv
conclusionsnw
ldh
level
young
children
bronchiol
vari
accord
viral
etiolog
diseas
sever
valu
upper
quartil
associ
risk
reduct
hospit
like
reflect
robust
antivir
respons
nw
ldh
may
use
biomark
assist
clinician
decis
hospit
child
bronchiol
bronchiol
acut
lower
respiratori
tract
ill
affect
bronchiol
infant
young
children
predominantli
viral
diseas
number
case
agent
identifi
decreas
year
widespread
use
sensit
diagnost
techniqu
recognit
new
virus
respiratori
syncyti
viru
rsv
chief
caus
hospit
respiratori
tract
ill
young
children
common
agent
recov
children
bronchiol
need
biochem
marker
diseas
sever
assist
clinician
determin
need
hospit
children
bronchiol
lactat
dehydrogenas
ldh
may
biochem
marker
relat
tissu
injuri
ldh
membraneassoci
protein
involv
oxid
variou
organ
substrat
present
major
organ
system
found
extracellularli
indic
cell
damag
inflamm
measur
ldh
bronchoalveolar
fluid
commonli
done
surrog
presenc
leukocyt
overal
inflamm
children
rsv
bronchiol
neutrophil
account
total
cell
nasal
wash
nw
bronchoalveolar
fluid
ldh
activ
nw
serum
report
children
bronchiol
postul
ldh
would
directli
correl
proinflammatori
immun
respons
observ
bronchiol
would
use
biochem
marker
diseas
sever
measur
ldh
nw
serum
specimen
cohort
children
bronchiol
report
previous
find
indic
nw
ldh
level
greater
children
less
sever
bronchiol
independ
associ
diseas
outcom
may
constitut
new
clinic
tool
allow
physician
better
establish
risk
diseas
progress
find
direct
agreement
prior
observ
report
benefit
robust
proinflammatori
innat
respons
amelior
bronchiol
diseas
aspect
studi
detail
previous
consist
prospect
investig
children
month
old
present
emerg
depart
ed
bronchiol
novemb
februari
children
present
respiratori
distress
unrel
virallik
respiratori
ill
exclud
studi
approv
institut
review
board
baylor
colleg
medicin
texa
children
hospit
bronchiol
defin
acut
lower
airway
infect
presenc
tachypnea
crackl
wheez
andor
retract
histori
previou
upperairway
infect
defin
nasal
congest
andor
rhinorrhea
diagnos
experienc
pediatr
ed
physician
decis
hospit
patient
discret
attend
physician
follow
standard
clinic
pathway
paramet
diseas
sever
includ
need
hospit
oxygen
supplement
intraven
fluid
requir
intub
arriv
ed
parent
consent
obtain
studi
personnel
record
patient
demograph
clinic
inform
conduct
physic
examin
nasalwash
sampl
obtain
use
standard
procedur
viral
transport
medium
ad
final
dilut
aliquot
made
snappedfrozen
dri
icealcohol
bath
store
c
viral
identif
done
origin
report
tissu
cultur
reversetranscriptas
polymeras
chain
reaction
rtpcr
allow
viral
detect
enrol
children
preval
viral
coinfect
report
improv
detect
virus
test
specimen
realtim
rtpcr
use
specif
primer
fluoresc
probe
rsv
human
metapneumoviru
hmpv
human
rhinoviru
result
new
diagnos
rhinoviru
two
rsv
infect
subtyp
b
made
new
case
hmpv
infect
detect
rsv
concentr
quantifi
use
method
firstli
rsvposit
sampl
titrat
plaqu
assay
duplic
report
plaqu
form
unit
per
millilit
pfuml
previous
describ
secondli
sampl
analyz
realtim
rtpcr
blind
quantit
cultur
result
calibr
standard
target
assay
parallel
sampl
number
cycl
requir
fluoresc
signal
reach
threshold
level
record
cross
threshold
therefor
lower
cross
threshold
higher
amount
genom
materi
vice
versa
nw
sampl
test
cytokin
chemokin
bioplex
human
cytokin
panel
biorad
laboratori
hercul
ca
follow
manufactur
instruct
lower
limit
detect
cytokin
chemokin
pgml
valu
previous
report
total
protein
quantifi
nasal
secret
bicinchonin
acid
method
pierc
bca
protein
assay
kit
thermo
scientif
rockford
il
follow
manufactur
instruct
express
microgram
per
millilit
total
ldh
activ
test
nw
sampl
sera
nw
serum
specimen
dilut
phosphatebuff
salin
respect
assay
duplic
follow
protocol
instruct
cytotox
detect
kit
roch
appli
scienc
indianapoli
calcul
absolut
valu
lldh
roch
appli
scienc
use
construct
standard
curv
demonstr
ampl
linear
dynam
rang
dilut
test
uml
concentr
ldh
nw
sampl
adjust
fourfold
dilut
result
specimen
collect
ldh
releas
may
marker
cell
destruct
caus
viru
host
cellular
immun
respons
may
due
apoptosi
induc
viru
innat
immun
respons
measur
apoptosi
nasal
secret
kit
promega
madison
wi
use
luminesc
measur
fluostar
optima
micropl
reader
bmg
labtech
cari
nc
express
rel
luminesc
unit
ldh
concentr
nw
serum
sampl
caspas
activ
normal
log
transform
statist
evalu
normal
distribut
continu
variabl
perform
student
test
analysi
varianc
appropri
differ
proport
nonparametr
data
compar
test
correl
calcul
pearson
spearman
coeffici
appropri
statist
signific
establish
test
level
p
associ
hospit
defin
hospit
stay
hour
independ
variabl
investig
multivari
logist
regress
analys
factor
identifi
univari
analysi
includ
model
associ
outcom
p
valu
less
initi
model
contain
follow
categor
variabl
age
month
fever
ye
hypoxia
ye
administr
intraven
fluid
ye
detect
viral
pathogen
ye
nw
ldh
concentr
caspas
activ
classifi
quartil
inclus
model
remov
fever
detect
viru
caspas
activ
final
model
contribut
goodnessoffit
model
describ
detail
previou
studi
children
bronchiol
enrol
ed
texa
children
hospit
two
patient
exclud
analys
violat
inclus
criteria
anoth
withdrew
consent
one
specimen
lost
transit
laboratori
although
clinic
inform
retain
nw
sampl
avail
viral
diagnosi
subject
clinic
data
avail
patient
known
caspas
level
patient
known
ldh
concentr
nw
total
number
children
analys
reflect
miss
data
median
age
present
month
rang
boy
fortysix
percent
famili
histori
asthma
histori
eczema
median
durat
ill
time
present
ed
day
mean
sd
day
specif
viral
etiolog
determin
patient
tabl
rsv
infect
lead
caus
bronchiol
present
individu
rhinoviru
second
frequenc
detect
case
note
patient
dual
infect
analysi
rsv
subgroup
reveal
case
rsva
case
rsvb
differ
children
b
strain
respect
hospit
need
mechan
ventil
oxygen
requir
hour
ivf
requir
hour
mean
concentr
ldh
nw
sampl
data
shown
proport
rsv
infect
subject
compar
hospit
versu
discharg
home
ed
p
differ
nw
ldh
concentr
accord
age
gender
race
hispan
latino
ethnic
famili
histori
atopi
environment
exposur
tobacco
smoke
day
care
attend
exposur
young
children
nw
ldh
concentr
determin
studi
popul
fig
level
significantli
differ
children
follow
age
group
month
data
shown
correl
observ
concentr
ldh
serum
nw
fluid
spearman
p
observ
vitro
increas
rsv
replic
respiratori
epitheli
cell
result
greater
concentr
ldh
supernat
effect
potenti
presenc
proinflammatori
cytokin
correl
nw
ldh
infecti
rsv
measur
plaqu
assay
fail
reach
statist
signific
p
fig
howev
signific
correl
notic
rsv
load
quantifi
subgroupspecif
realtim
pcr
rsva
r
p
rsvb
r
p
fig
b
c
total
protein
content
nw
fluid
may
combin
protein
releas
virusinduc
epitheli
cell
injuri
host
immun
respons
expect
signific
correl
observ
nw
total
protein
nw
ldh
concentr
r
p
fig
helper
th
cytokin
interferon
tumor
necrosi
factor
cytokin
proinflammatori
cytokin
macrophag
inflammatori
protein
monocyt
chemoattract
protein
granulocytemacrophag
colonystimul
factor
gmcsf
granulocyt
colonystimul
factor
detect
nw
fluid
sampl
strongli
correl
ldh
nw
sampl
tabl
posit
linear
correl
observ
nw
ldh
nw
caspas
measur
apoptosi
activ
r
p
fig
classic
indic
bronchiol
sever
shown
tabl
respect
level
nw
ldh
children
bronchiol
discharg
home
hospit
ed
significantli
higher
nw
ldh
concentr
admit
support
care
vs
uml
p
fig
hospit
occur
children
age
month
respect
approxim
half
hospit
patient
requir
supplement
oxygen
patient
receiv
oxygen
hour
lower
nw
ldh
level
compar
children
receiv
hour
oxygen
although
differ
disappear
consid
children
hospit
data
shown
patient
high
level
nw
ldh
receiv
shorter
durat
oxygen
supplement
none
wilcoxon
ranksum
test
z
p
intub
associ
differ
nw
ldh
patient
requir
mechan
ventil
collect
data
indic
sever
clinic
present
lead
hospit
associ
lower
level
nw
ldh
concentr
quartil
distribut
nw
ldh
follow
lowquartil
group
uml
midquartil
uml
highquartil
uml
univari
analysi
identifi
follow
variabl
inclus
multivari
logist
regress
analysi
hospit
presenc
fever
odd
ratio
p
need
intraven
fluid
p
detect
viral
pathogen
p
age
month
p
nw
ldh
concentr
percentil
p
nwcaspas
activ
percentil
p
presenc
hypoxia
p
final
multivari
predict
model
hospit
among
children
present
ed
bronchiol
present
tabl
model
age
month
presenc
hypoxia
associ
increas
hospit
respect
high
concentr
nw
ldh
uml
associ
reduct
need
admiss
p
final
model
gave
area
receiv
oper
characterist
roc
curv
pearson
goodnessoffit
test
statist
p
fig
assum
predict
probabl
hospit
cutoff
valu
model
correctli
classifi
patient
observ
avail
inclus
logist
regress
twelv
patient
would
incorrectli
sent
home
fals
neg
rate
sensit
specif
posit
predict
valu
neg
predict
valu
respect
best
knowledg
first
descript
ldh
nw
specimen
young
children
bronchiol
nw
ldh
found
signific
independ
biochem
marker
reduc
risk
hospit
observ
nw
ldh
level
significantli
higher
children
sent
home
ed
compar
admit
bronchiol
p
strongli
correl
apoptosi
marker
caspas
cytokin
chemokin
involv
innat
adapt
immun
respons
detect
virus
associ
higher
nw
ldh
valu
import
note
nw
ldh
correl
serum
ldh
impli
nw
ldh
origin
cellular
event
occur
respiratori
airway
observ
correl
nw
serum
ldh
indic
ldh
nasal
secret
unlik
deriv
capillari
extravas
protein
airway
support
notion
studi
evalu
ldh
concentr
bronchoalveolar
fluid
conclud
sourc
differ
serum
consid
relat
nwtoserum
ldh
ratio
factor
like
present
children
sent
home
ed
compar
admit
support
care
p
data
shown
thu
reason
hypothes
ldh
origin
widespread
airway
epitheli
cell
injuri
apoptosi
leukocyt
larg
polymorphonuclear
cell
present
nw
fluid
strong
correl
nw
ldh
gmcsf
support
polymorphonuclear
cell
leukocyt
sourc
ldh
near
linear
correl
caspas
suggest
apoptosi
contribut
nw
ldh
better
understand
sourc
nw
ldh
may
provid
addit
inform
earli
innat
mechan
involv
virusinduc
bronchiol
rsv
major
etiolog
agent
bronchiol
data
reflect
fact
case
attribut
rsv
intuit
elev
concentr
rsv
close
link
sever
bronchiol
diseas
previou
studi
support
theori
devincenzo
et
al
analyz
infant
infect
rsv
hospit
winter
season
marker
diseas
sever
includ
requir
intens
care
respiratori
failur
durat
hospit
increas
nw
rsv
load
signific
independ
predictor
marker
diseas
sever
buckingham
et
al
studi
rsv
infect
hospit
mean
nw
concentr
significantli
higher
patient
requir
mechan
ventil
compar
contrast
wright
et
al
examin
rsv
titer
nw
sampl
infant
hospit
bronchiol
find
demonstr
correl
viral
titer
sever
ill
martin
et
al
describ
patient
respiratori
infect
attribut
rsv
adjust
age
presenc
comorbid
frequenc
hospit
decreas
log
increas
viral
load
ci
p
strong
correl
observ
nw
ldh
rsv
viral
load
quantifi
realtim
pcr
present
infecti
viru
assess
p
plaqu
assay
fig
attribut
discrep
possibl
presenc
rsv
neutral
antibodi
nasal
secret
disprov
wright
et
al
increas
precis
pcr
tradit
method
disprov
bae
et
al
signific
correl
observ
nw
ldh
variou
cytokin
chemokin
may
reflect
activ
parallel
biolog
respons
relat
viral
infect
innat
adapt
immun
system
activ
aberr
immun
respons
mutat
gene
involv
innat
immun
link
rsv
bronchiol
suscept
sever
howev
recent
data
suggest
cytokin
level
necessarili
correl
diseas
present
welliv
et
al
show
infant
fatal
rsv
lower
respiratori
tract
diseas
succumb
overwhelm
viral
infect
epitheli
cell
apoptosi
cytokin
storm
lung
section
character
pauciti
lymphocyt
natur
killer
cell
uncheck
viral
replic
apoptot
crisi
recent
studi
support
concept
protect
effect
deriv
robust
innat
immun
respons
episod
rsv
bronchiol
inflammatori
marker
invers
correl
diseas
sever
date
biochem
marker
predict
diseas
sever
children
bronchiol
studi
sensit
specif
nw
ldh
predict
hospit
respect
valu
compar
mani
pointofcar
test
use
diagnos
viral
infect
ldh
assay
easi
perform
inexpens
avail
clinic
laboratori
institut
expect
turnaround
time
serum
ldh
hour
nw
sampl
treat
differ
current
presenc
hypoxemia
signific
respiratori
distress
clinic
judgment
main
consider
determin
need
hospit
child
bronchiol
valid
biochem
marker
predict
hospit
provid
anoth
object
paramet
physician
would
valuabl
difficulttoassess
case
limit
studi
singl
nw
sampl
obtain
patient
sever
diseas
determin
final
disposit
patient
need
therapeut
intervent
therefor
diseas
progress
may
occur
patient
discharg
hospit
data
collect
singl
season
rsv
preval
therefor
weight
impact
result
origin
singl
center
recogn
repeat
sampl
andor
longer
followup
patient
would
strengthen
conclus
despit
limit
result
consist
multipl
clinic
outcom
support
valid
conclus
studi
strengthen
comprehens
effort
character
viral
agent
assess
complex
interplay
rsv
concentr
inflammatori
respons
patient
age
sever
bronchiol
addit
includ
children
mild
sever
bronchiol
ed
set
critic
comprehens
analysi
addit
evalu
hypothesi
warrant
add
better
understand
immunopathogenesi
bronchiol
determin
ldh
nw
potenti
use
clinic
biochem
marker
diseas
sever
among
children
bronchiol
studi
valid
observ
need
nw
ldh
incorpor
clinic
decis
whether
safe
discharg
hospit
young
child
present
ed
mild
moder
sever
bronchiol
correl
ldh
caspas
activ
nw
sampl
rlu
indic
rel
luminesc
unit
roc
curv
multivari
logist
analysi
present
tabl
